Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go?
Journal
European Journal of Cancer
Journal Volume
103
Pages
32-40
Date Issued
2018
Author(s)
Publisher
Elsevier Ltd
Type
journal article